HASelect-Medical Receivables Litigation Finance Fund International SP
Raised
$15M
Investors
59
Min Invest
$250,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
AltStreet Analysis
·Generated from EDGAR primary sources
HASelect-Medical Receivables Litigation Finance Fund International SP is a Cayman Islands segregated portfolio vehicle that filed an amended Form D on 2020-07-21, reporting $15.0M raised from 59 investors at a $250K minimum investment under Rule 506(b) and Section 3(c)(1) exemptions. The filing lists Griffin Capital MGT, LLC and Griffin Asset Management LLC, along with individuals Michael Griffin and James Gallagher, as the controlling persons; no parent platform or sibling entities are currently matched in the database.
This is a privately placed pooled investment fund targeting litigation finance receivables, a niche alternative asset class, structured through an offshore (Cayman Islands) segregated portfolio and sold to a limited pool of accredited/qualified investors. The $250K minimum and combined 506(b)/3(c)(1) exemption structure are typical of small-to-mid-size private funds limiting investor count to stay under the 3(c)(1) 100-investor threshold.
Data Flags
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Reporting lapsed · Form D · last filing July 21, 2020
Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
dark
Investor
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2020-07-21: 1 related person added and 2 removed against the filing of 2019-03-25; 4 now listed. The names are in the Terminal feed.
. Griffin Capital MGT, LLC
Director · La Grange, IL
. Griffin Asset Management LLC
Executive Officer · La Grange, IL
Michael Griffin
Executive Officer · La Grange, IL
James Gallagher
Executive Officer · La Grange, IL
Questions About HASelect-Medical Receivables Litigation Finance Fund International SP
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is HASelect-Medical Receivables Litigation Finance Fund International SP?
HASelect-Medical Receivables Litigation Finance Fund International SP is a Cayman Islands entity that filed a Form D with the SEC on July 21, 2020 as a hedge fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of pooled investment fund interests.
Is HASelect-Medical Receivables Litigation Finance Fund International SP legit?
AltStreet does not rate legitimacy; it reports the public record. HASelect-Medical Receivables Litigation Finance Fund International SP filed a Form D with the SEC on July 21, 2020 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $15,011,000 sold to 59 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is HASelect-Medical Receivables Litigation Finance Fund International SP registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that HASelect-Medical Receivables Litigation Finance Fund International SP claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has HASelect-Medical Receivables Litigation Finance Fund International SP raised?
HASelect-Medical Receivables Litigation Finance Fund International SP reported $15,011,000 sold from 59 investors in an offering of indefinite size as of the Form D filed July 21, 2020.
Who can invest in HASelect-Medical Receivables Litigation Finance Fund International SP?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000.
What is the minimum investment in HASelect-Medical Receivables Litigation Finance Fund International SP?
The Form D lists $250,000 as the minimum investment accepted from any outside investor as of July 21, 2020. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling HASelect-Medical Receivables Litigation Finance Fund International SP and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.
Who is behind HASelect-Medical Receivables Litigation Finance Fund International SP?
The Form D lists 4 related persons: Griffin Capital MGT, LLC, director (Sole holder of the Company's Management Shares); Griffin Asset Management LLC, executive officer (Investment Manager); Michael Griffin, executive officer (Managing Member of the sole holder of Management Shares); James Gallagher, executive officer (Principal of the sole holder of Management Shares). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is HASelect-Medical Receivables Litigation Finance Fund International SP located?
The issuer's address on its SEC filings is 403 South La Grange Road, La Grange, IL 60525. Its phone number of record is 3129520685. It is organized under the laws of Cayman Islands.
How long is the HASelect-Medical Receivables Litigation Finance Fund International SP offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.
How large is HASelect-Medical Receivables Litigation Finance Fund International SP?
The issuer declined to disclose its net asset value range on the Form D, which the form permits.

Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
